MAPT and Alzheimer disease: More specifically, the evolution of NFTs in AD follows a progression of phosphorylated tau modifications from TG3 (phosphospecific at Thr231), found in preneurofibrillary tangles (preNFTs), to AT8 and PHF-1 in intraneuronal and extraneuronal NFTs [61].